Regulated vascular smooth muscle cell death in vascular diseases

Zheng Yin , Jishou Zhang , Zican Shen , Juan-Juan Qin , Jun Wan , Menglong Wang

Cell Proliferation ›› 2024, Vol. 57 ›› Issue (11) : e13688

PDF
Cell Proliferation ›› 2024, Vol. 57 ›› Issue (11) : e13688 DOI: 10.1111/cpr.13688
REVIEW

Regulated vascular smooth muscle cell death in vascular diseases

Author information +
History +
PDF

Abstract

Regulated cell death (RCD) is a complex process that involves several cell types and plays a crucial role in vascular diseases. Vascular smooth muscle cells (VSMCs) are the predominant elements of the medial layer of blood vessels, and their regulated death contributes to the pathogenesis of vascular diseases. The types of regulated VSMC death include apoptosis, necroptosis, pyroptosis, ferroptosis, parthanatos, and autophagy-dependent cell death (ADCD). In this review, we summarize the current evidence of regulated VSMC death pathways in major vascular diseases, such as atherosclerosis, vascular calcification, aortic aneurysm and dissection, hypertension, pulmonary arterial hypertension, neointimal hyperplasia, and inherited vascular diseases. All forms of RCD constitute a single, coordinated cell death system in which one pathway can compensate for another during disease progression. Pharmacologically targeting RCD pathways has potential for slowing and reversing disease progression, but challenges remain. A better understanding of the role of regulated VSMC death in vascular diseases and the underlying mechanisms may lead to novel pharmacological developments and help clinicians address the residual cardiovascular risk in patients with cardiovascular diseases.

Cite this article

Download citation ▾
Zheng Yin, Jishou Zhang, Zican Shen, Juan-Juan Qin, Jun Wan, Menglong Wang. Regulated vascular smooth muscle cell death in vascular diseases. Cell Proliferation, 2024, 57(11): e13688 DOI:10.1111/cpr.13688

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

2024 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.

AI Summary AI Mindmap
PDF

113

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/